IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: As an alternative mechanism, IFN induces specific immunity against CML and T cells specific for leukemia-associated antigens (LAA) can target leukemia progenitors and contribute to CR[15], [16].